Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture

Experimental Neurology

Volumn 253, Issue , 2014, Pages 146-153

  Pittman, Sherry K ^a   Gracias, Neilia G ^a,b   Vasko, Michael R ^a   Fehrenbacher, Jill C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

CGRP; Chemotherapy induced peripheral neuropathy; Dorsal root ganglion culture; Neuropeptide release; Neurotoxicity; Paclitaxel; Peripheral sensory neuron; TRPA1; TRPV1

Indexed keywords

ALLYL ISOTHIOCYANATE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; PACLITAXEL; POTASSIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVOKED RESPONSE; EXTRACELLULAR SPACE; MALE; NERVE CELL GROWTH; NERVE CELL STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SENSORY NERVE CELL; SPINAL GANGLION;

CGRP; CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY; DORSAL ROOT GANGLION CULTURE; NEUROPEPTIDE RELEASE; NEUROTOXICITY; PACLITAXEL; PERIPHERAL SENSORY NEURON; TRPA1; TRPV1;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCITONIN GENE-RELATED PEPTIDE; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GANGLIA, SPINAL; HYDROGEN PEROXIDE; ISOTHIOCYANATES; MALE; OXIDANTS; PACLITAXEL; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; TIME FACTORS; TRPV CATION CHANNELS;

EID: 84892532747     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.12.011     Document Type: Article

References (67)

1. Alpizar Y.A., Boonen B., Gees M., Sanchez A., Nilius B., Voets T., Talavera K. Allyl isothiocyanate sensitizes TRPV1 to heat stimulation. Pflugers Arch. - Eur. J. Physiol.(Electronic publication ahead of print). 2013.
2. Authier N., Gillet J.P., Fialip J., Eschalier A., Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain. Res. 2000, 887:239-249.
3. Barabas M.E., Kossyreva E.A., Stucky C.L. TRPA1 is functionally expressed primarily by IB4-binding, non-peptidergic mouse and rat sensory neurons. PLoS. ONE. 2012, 7:e47988.
4. Bennett G.J., Liu G.K., Xiao W.H., Jin H.W., Siau C. Terminal arbor degeneration-a novel lesion produced by the antineoplastic agent paclitaxel. Eur. J. Neurosci. 2011, 33:1667-1676.
5. Boehmerle W., Splittgerber U., Lazarus M.B., McKenzie K.M., Johnston D.G., Austin D.J., Ehrlich B.E. Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18356-18361.
6. Boyette-Davis J., Xin W., Zhang H., Dougherty P.M. Intraepidermal nerve fiber loss corresponds to the development of Taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain 2011, 152:308-313.
7. Campana W.M., Eskeland N., Calcutt N.A., Misasi R., Myers R.R., O'Brien J.S. Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology 1998, 19:237-244.
8. Capri G., Tarenzi E., Fulfaro F., Gianni L. The role of taxanes in the treatment of breast cancer. Semin. Oncol. 1996, 23:68-75.
9. Cata J.P., Weng H.R., Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res. 2008, 1229:100-110.
10. Cavaletti G., Cavalletti E., Montaguti P., Oggioni N., De Negri O., Tredici G. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology 1997, 18:137-145.
11. Cavaletti G., Cavalletti E., Oggioni N., Sottani C., Minoia C., D'Incalci M., Zucchetti M., Marmiroli P., Tredici G. Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology 2000, 21:389-393.
12. Chen Y., Yang C., Wang Z.J. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 2011, 193:440-451.
13. Connelly E., Markman M., Kennedy A., Webster K., Kulp B., Peterson G., Belinson J. Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity. Gynecol. Oncol. 1996, 62:166-168.
14. Deng L., Guindon J., Vemuri V.K., Thakur G.A., White F.A., Makriyannis A., Hohmann A.G. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB(2) receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy. Mol. Pain 2012, 8:71.
15. Dougherty P.M., Cata J.P., Cordella J.V., Burton A., Weng H.R. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004, 109:132-142.
16. Dunham J.P., Leith J.L., Lumb B.M., Donaldson L.F. Transient receptor potential channel A1 and noxious cold responses in rat cutaneous nociceptors. Neuroscience 2010, 165:1412-1419.
17. Everaerts W., Gees M., Alpizar Y.A., Farre R., Leten C., Apetrei A., Dewachter I., van Leuven F., Vennekens R., De Ridder D., Nilius B., Voets T., Talavera K. The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oi. Curr. Biol. 2011, 21:316-321.
18. Ferlini C., Cicchillitti L., Raspaglio G., Bartollino S., Cimitan S., Bertucci C., Mozzetti S., Gallo D., Persico M., Fattorusso C., Campiani G., Scambia G. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res. 2009, 69:6906-6914.
19. Flatters S.J., Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 2006, 122:245-257.
20. Flatters S.J., Xiao W.H., Bennett G.J. Acetyl-l-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci. Lett. 2006, 397:219-223.
21. Forsyth P.A., Balmaceda C., Peterson K., Seidman A.D., Brasher P., DeAngelis L.M. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J. Neurooncol. 1997, 35:47-53.
22. Gambino F., Pavlowsky A., Begle A., Dupont J.L., Bahi N., Courjaret R., Gardette R., Hadjkacem H., Skala H., Poulain B., Chelly J., Vitale N., Humeau Y. IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2± channel and neurite elongation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9063-9068.
23. Gees M., Alpizar Y.A., Boonen B., Sanchez A., Everaerts W., Segal A., Xue F., Janssens A., Owsianik G., Nilius B., Voets T., Talavera K. Mechanisms of transient receptor potential vanilloid 1 activation and sensitization by allyl isothiocyanate. Mol. Pharmacol. 2013, 84:325-334.
24. Gracias N.G., Cummins T.R., Kelley M.R., Basile D.P., Iqbal T., Vasko M.R. Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel. Neurotoxicology 2011, 32:140-149.
25. Hara T., Chiba T., Abe K., Makabe A., Ikeno S., Kawakami K., Utsunomiya I., Hama T., Taguchi K. Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion. Pain 2013, 154:882-889.
26. Henningsson A., Karlsson M.O., Vigano L., Gianni L., Verweij J., Sparreboom A. Mechanism-based pharmacokinetic model for paclitaxel. J. Clin. Oncol. 2001, 19:4065-4073.
27. Hershman D.L., Unger J.M., Crew K.D., Moinpour C., Minasian L.M., Hansen L., Lew D., OKane P., Wade J.L., Wong S.-F., Hortobagyi G.N., Meyskens F.L., Albain K.S. SWOG S0715: Randomized placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy during adjuvant breast cancer therapy. ASCO Meeting Abstracts 2012, 30:9018.
28. Hingtgen C.M., Vasko M.R. Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res. 1994, 655:51-60.
29. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988, 24:739-768.
30. Ito S., Tajima K., Nogawa M., Inoue N., Kyoi T., Takahashi Y., Sasagawa T., Nakamura A., Kotera T., Ueda M., Yamashita Y., Banno K. Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia. J. Pharmacol. Exp. Ther. 2012, 342:53-60.
31. Jin H.W., Flatters S.J., Xiao W.H., Mulhern H.L., Bennett G.J. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-l-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp. Neurol. 2008, 210:229-237.
32. Kautio A.L., Haanpaa M., Leminen A., Kalso E., Kautiainen H., Saarto T. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms. Anticancer Res. 2009, 29:2601-2606.
33. Kawakami K., Chiba T., Katagiri N., Saduka M., Abe K., Utsunomiya I., Hama T., Taguchi K. Paclitaxel increases high voltage-dependent calcium channel current in dorsal root ganglion neurons of the rat. J. Pharmacol. Sci. 2012.
34. Kidd J.F., Pilkington M.F., Schell M.J., Fogarty K.E., Skepper J.N., Taylor C.W., Thorn P. Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J. Biol. Chem. 2002, 277:6504-6510.
35. Kim H.K., Zhang Y.P., Gwak Y.S., Abdi S. Phenyl N-tert-butylnitrone, a free radical scavenger, reduces mechanical allodynia in chemotherapy-induced neuropathic pain in rats. Anesthesiology 2010, 112:432-439.
36. Koliatsos V.E., Price D.L. Axotomy as an experimental model of neuronal injury and cell death. Brain Pathol. 1996, 6:447-465.
37. Kottschade L.A., Sloan J.A., Mazurczak M.A., Johnson D.B., Murphy B.P., Rowland K.M., Smith D.A., Berg A.R., Stella P.J., Loprinzi C.L. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer 2011, 19:1769-1777.
38. Kunkler P.E., Ballard C.J., Oxford G.S., Hurley J.H. TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation. Pain 2011, 152:38-44.
39. Kwan K.Y., Allchorne A.J., Vollrath M.A., Christensen A.P., Zhang D.S., Woolf C.J., Corey D.P. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 2006, 50:277-289.
40. LaPointe N.E., Morfini G., Brady S.T., Feinstein S.C., Wilson L., Jordan M.A. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology 2013, 37:231-239.
41. Lipton R.B., Apfel S.C., Dutcher J.P., Rosenberg R., Kaplan J., Berger A., Einzig A.I., Wiernik P., Schaumburg H.H. Taxol produces a predominantly sensory neuropathy. Neurology 1989, 39:368-373.
42. Manfredi J.J., Parness J., Horwitz S.B. Taxol binds to cellular microtubules. J. Cell Biol. 1982, 94:688-696.
43. Materazzi S., Fusi C., Benemei S., Pedretti P., Patacchini R., Nilius B., Prenen J., Creminon C., Geppetti P., Nassini R. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism. Pflugers Arch. - Eur. J. Physiol. 2012, 463:561-569.
44. Matsumoto M., Inoue M., Hald A., Xie W., Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J. Pharmacol. Exp. Ther. 2006, 318:735-740.
45. McCoy E.S., Taylor-Blake B., Street S.E., Pribisko A.L., Zheng J., Zylka M.J. Peptidergic CGRPalpha primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold. Neuron 2013, 78:138-151.
46. Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., Taroni F., Lauria G. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp. Neurol. 2008, 214:276-284.
47. Miyano K., Tang H.B., Nakamura Y., Morioka N., Inoue A., Nakata Y. Paclitaxel and vinorelbine, evoked the release of substance P from cultured rat dorsal root ganglion cells through different PKC isoform-sensitive ion channels. Neuropharmacology 2009, 57:25-32.
48. Mo M., Erdelyi I., Szigeti-Buck K., Benbow J.H., Ehrlich B.E. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J. 2012, 26:4696-4709.
49. Park K.A., Fehrenbacher J.C., Thompson E.L., Duarte D.B., Hingtgen C.M., Vasko M.R. Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons. Neuroscience 2010, 171:910-923.
50. Pascual D., Goicoechea C., Suardiaz M., Martin M.I. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats. Pain 2005, 118:23-34.
51. Polomano R.C., Mannes A.J., Clark U.S., Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001, 94:293-304.
52. Rao R.D., Michalak J.C., Sloan J.A., Loprinzi C.L., Soori G.S., Nikcevich D.A., Warner D.O., Novotny P., Kutteh L.A., Wong G.Y. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007, 110:2110-2118.
53. Rao R.D., Flynn P.J., Sloan J.A., Wong G.Y., Novotny P., Johnson D.B., Gross H.M., Renno S.I., Nashawaty M., Loprinzi C.L. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008, 112:2802-2808.
54. Rowinsky E.K., Gilbert M.R., McGuire W.P., Noe D.A., Grochow L.B., Forastiere A.A., Ettinger D.S., Lubejko B.G., Clark B., Sartorius S.E., et al. Sequences of taxol and cisplatin: a phase I and pharmacologic study. J. Clin. Oncol. 1991, 9:1692-1703.
55. Rowinsky E.K., Jiroutek M., Bonomi P., Johnson D., Baker S.D. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin. Clin. Cancer Res. 1999, 5:767-774.
56. Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277:665-667.
57. Scuteri A., Nicolini G., Miloso M., Bossi M., Cavaletti G., Windebank A.J., Tredici G. Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells. Anticancer Res. 2006, 26:1065-1070.
58. Smith E.M., Pang H., Cirrincione C., Fleishman S., Paskett E.D., Ahles T., Bressler L.R., Fadul C.E., Knox C., Le-Lindqwister N., Gilman P.B., Shapiro C.L. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013, 309:1359-1367.
59. Vasko M.R., Campbell W.B., Waite K.J. Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 1994, 14:4987-4997.
60. Vasko M.R., Guo C., Kelley M.R. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA. Repair. 2005, 4:367-379.
61. Voehringer D.W. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. 1999, 27:945-950.
62. Whiteside G., Doyle C.A., Hunt S.P., Munglani R. Differential time course of neuronal and glial apoptosis in neonatal rat dorsal root ganglia after sciatic nerve axotomy. Eur. J. Neurosci. 1998, 10:3400-3408.
63. Wiernik P.H., Schwartz E.L., Strauman J.J., Dutcher J.P., Lipton R.B., Paietta E. Phase I clinical and pharmacokinetic study of taxol. Cancer Res. 1987, 47:2486-2493.
64. Xiao W., Boroujerdi A., Bennett G.J., Luo Z.D. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 2007, 144:714-720.
65. Xiao W.H., Zheng H., Zheng F.Y., Nuydens R., Meert T.F., Bennett G.J. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience 2011, 199:461-469.
66. Yang I.H., Siddique R., Hosmane S., Thakor N., Hoke A. Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration. Exp. Neurol. 2009, 218:124-128.
67. Zhang H., Boyette-Davis J.A., Kosturakis A.K., Li Y., Yoon S.Y., Walters E.T., Dougherty P.M. Induction of Monocyte Chemoattractant Protein-1 (MCP-1) and Its Receptor CCR2 in Primary Sensory Neurons Contributes to Paclitaxel-Induced Peripheral Neuropathy. J. Pain 2013.